Autoimmune Diseases of the Nervous System  >>  Soliris (eculizumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Soliris (eculizumab) / AstraZeneca
NCT00904826: An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica

Checkmark Relapsing NMOSD POC trial
Dec 2015 - Dec 2015: Relapsing NMOSD POC trial
Completed
1/2
14
US
Eculizumab, Soliris
Mayo Clinic, Alexion Pharmaceuticals
Neuromyelitis Optica, Devic's Disease
12/11
12/11

Download Options